SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 19.27 |
Enterprise Value ($M) | -1.82 |
Book Value ($M) | 28.16 |
Book Value / Share | 1.04 |
Price / Book | 0.68 |
NCAV ($M) | 26.22 |
NCAV / Share | 0.97 |
Price / NCAV | 0.73 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.09 |
Return on Assets (ROA) | -0.48 |
Return on Equity (ROE) | -0.61 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.07 |
Current Ratio | 7.07 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 30.54 |
Assets | 32.48 |
Liabilities | 4.32 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -36.46 |
Net Income | -38.35 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -36.91 |
Cash from Investing | 22.33 |
Cash from Financing | 2.88 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Otto Erik | 6.70 | ||
13D/A | Orbimed Advisors Llc | 2.80 | -34.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,405 | 22,888 | 10.51 | |
36,694 | 46,784 | 78.43 | |
3,460 | 10,178 | 33.99 | |
36,975 | 48,317 | 76.53 | |
9,902 | 14,473 | 68.42 | |
(click for more detail) |
Similar Companies | |
---|---|
GHSI – Guardion Health Sciences, Inc. | GLMD – Galmed Pharmaceuticals Ltd. |
GLSI – Greenwich LifeSciences, Inc. | GNLX – Genelux Corporation |
GNPX – Genprex, Inc. |
Financial data and stock pages provided by
Fintel.io